Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Hospital EMR Systems Market: Market Segments: By Product Type (Inpatient EMR and Outpatient EMR); By Component (Software and Services); By Application (Cardiology, Neurology, Radiology, Oncology and Others); By End-User (Hospital-based EMR and Physician-based EMR); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030
... Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030 Product Overview Hospital EMR systems are also known as Electronic Health Records (EHR) systems. These systems may ... Read More
-
Human Papillomavirus Vaccine Market By Type (Tetravalent, Nonavalent, Bivalent), By Disease Indication (Cervical Cancer, Anal Cancer, Vulvar & Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Others), By Industry Vertical (Public and Private Alliances, Government Entities, Physicians, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
... Others): Global Opportunity Analysis and Industry Forecast, 2021-2030 The global human papillomavirus vaccine market size was valued at $3,892.7 million in 2021 and is projected to reach $10,823.0 million by 2030, growing at a CAGR ... Read More
-
2022 Global Forecast for Angioimmunoblastic T-Cell Lymphoma (Ailt) Treatment Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... over 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or ... Read More
-
Global Total Fluid Management Market: Market Segments: By Product Type [Infusion Therapy Products (Infusion Devices, IV Access devices, IV Solutions and Products), Renal Products (In-Center Hemodialysis Products, Home Hemodialysis (HHD) Products, Peritoneal dialysis Products, Acute Dialysis Products), Endoscopy Fluid Management Products]; By Application (Urology, Cardiology, Orthopedic/Osteology, Neurology, Oncology, Gastroenterology, Others); By End-user (Hospitals, Clinics, Dialysis Centers, Home Care Settings); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030
... Dialysis Products), Endoscopy Fluid Management Products]; By Application (Urology, Cardiology, Orthopedic/Osteology, Neurology, Oncology, Gastroenterology, Others); By End-user (Hospitals, Clinics, Dialysis Centers, Home Care Settings); and Region – Analysis of Market Size, Share & Trends for ... Read More
-
Malignant Mesothelioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Malignant Mesothelioma (Oncology) pipeline landscape. Malignant pleural mesothelioma is a rare cancer often diagnosed in people who have been exposed to high levels of asbestos. The malignancy affects the pleura, ... Read More
-
Europe Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Country and Growth Forecast, 2022 - 2028
... The Europe Antibody Drug Conjugates Market would witness market growth of 13.8% CAGR during the forecast period (2022-2028). Antigens expressed predominantly on the surface of tumor cells are ideal targets for ADCs. Hematological malignancies express ... Read More
-
North America Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Country and Growth Forecast, 2022 – 2028
... 2028 The North America Antibody Drug Conjugates Market would witness market growth of 13.7% CAGR during the forecast period (2022-2028). ADCs are anticancer medications that are one of the quickest treatments for cancer patients, with ... Read More
-
Cancer Anorexia-Cachexia Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline landscape. Cancer anorexia-cachexia syndrome is defined as progressive weight loss associated with malignancy and is characterized by loss of appetite (anorexia), skeletal muscle ... Read More
-
Global Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Regional Outlook and Forecast, 2022 – 2028
... The Global Antibody Drug Conjugates Market size is expected to reach $13.8 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period. Antibody Drug Conjugates (ADCs) are biopharmaceutical drugs that ... Read More
-
Computed Tomography Market, By Types (Stationary CT Scanners, Portable CT Scanners), By Application (Human Application, Diagnostic Applications, Cardiology Applications, Oncology Applications, Neurology Applications, Other Diagnostic Applications, Intraop
... (Hospital and Research Centers, Diagnostic Imaging Centers), By (North America, Latin America, Europe, Asia Pacific, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Computed tomography (CT) is imaging process that ... Read More
-
Global Oncology Biosimilars Market Size study, By Indication (Atopic Dermatitis, Postoperative Immunosuppression, Ulcerative Colitis, Psoriasis, Keratoconjunctivitis, Others), By Drug Class (Cyclosporine, Tacrolimus, Pimecrolimus, Others), By Route of Administration (Oral, Topical, Parenteral), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028
... Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028 Global Oncology Biosimilars Market is valued approximately USD XX million in 2021 and is anticipated to grow with ... Read More
-
Hypopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Hypopharyngeal Cancer (Oncology) pipeline landscape. Hypopharyngeal cancer is a term used for tumors of a subsite of the upper aerodigestive tract, and like most other subsite designations, the distinction is ... Read More
-
Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) pipeline Target constitutes close to 6 molecules. Out of which approximately 6 molecules are developed by Companies. The latest report Bromodomain Testis Specific Protein - ... Read More
-
Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Thyroid Cancer (Oncology) pipeline landscape. Thyroid cancer is a cancer that starts in the thyroid gland. Symptoms include lump that can be felt through the skin on neck, difficulty swallowing, ... Read More
-
Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (PET and SPECT), PET Product (F-18, C-11, and Ga68-PSMA), and End User (Hospitals, Clinics, and Others)
... prostate cancer nuclear medicine diagnostics market is expected to grow from US$ 720.12 million in 2022 to US$ 1,315.66 million by 2028. It is estimated to grow at a CAGR of 10.6% from 2022 to ... Read More
-
Immuno-Oncology - Thematic Research
... not happened High cost of therapy and need for personalized treatment using biomarkers remain as unmet needs Scope Overview of immuno-oncology including classification of therapy and technologies, regulatory and market access details, product & company ... Read More
-
Gastric and Gastroesophageal Junction Adenocarcinoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
... fifth most common form of cancer: The standard of care in the first-line for both HER2-positive and -negative patients is now changing following the approvals of Opdivo in combination with chemotherapy for HER2-negative patients across ... Read More
-
Global Recombinant Vaccines Market, By Product Type (Subunit Recombinant Vaccines, Attenuated Recombinant Vaccines, Vector Recombinant Vaccines), Disease Type (Infectious Disease, Cancer, Allergy), End User (Recombinant Human Vaccines, Animal Recombinant
... Share, Opportunity Analysis, and Industry Forecast, 2022 - 2028 Report Description Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and ... Read More
-
Oncology Radiopharmaceuticals Market, by Test Type (Radium-223 dichloride, Sodium iodide I-131, Lobenguane iodine-131, Lutetium-177, Yttrium-90, Fludeoxyglucose F 18, Gallium Citrate Ga 67, Technetium-99m, and Others), by Route of Administration (Oral and
... and Treatment), by End User (Diagnostic Centres, Hospitals and Clinics, and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 ... Read More
-
Global Market Study on Bone Marrow Transplantation: Rising incidences of Cancer to drive market expansion
... Bone Marrow Transplantation Market including global industry analysis for 2013-2021 & opportunity assessment for 2022 - 2028, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical ... Read More
-
2022 Italy Cancer Diagnostics Market Shares - Competitive Analysis of Leading and Emerging Market Players
... reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: - Abbott Affymetrix Beckman Coulter/Danaher/Cepheid Becton Dickinson bioMerieux Bio-Rad ... Read More
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
Intravenous Immunoglobulin Market (Indication: Chronic Inflammatory Demyelinating Polyneuropathy, Primary Humoral Immunodeficiency, Idiopathic Thrombocytopenic Purpura, Guillain-Barre Syndrome, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Growth, Trends, and Forecast, 2022-2031 Companies Mentioned Baxalta Incorporated Biotest AG China Biologic Products, Inc. CSL Behring LLC Grifols S.A. Kedrion S.p.A. LFB Biomedicaments S.A. Octapharma AG Sanquin Plasma Products B.V." Countries North America Europe ... Read More
-
Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed ... Read More
-
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical trials scenario. This report provides ... Read More
Research Assistance
